Concomitant chemoradiotherapy for muscle-invasive bladder cancer: the way forward for bladder preservation?

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Clinics in oncology

• Publication date

  2005-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.CLON.2004.08.011PMID 15900999
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis.

  2003cited by this paper
• Chemoradiotherapy for cervical cancer.

  2002cited by this paper
• Anti-epidermal growth factor receptor drugs in cancer therapy

  2002cited by this paper
• Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer.

  2002cited by this paper
• Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results.

  2002cited by this paper
• Cystectomy for bladder cancer: a contemporary series.

  2001cited by this paper
• Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis.

  2001cited by this paper
• Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor.

  2001cited by this paper
• Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

  2001cited by this paper
• Complications of cystectomy in patients with a history of pelvic radiation.

  2001cited by this paper
• A phase I-II study of synchronous chemoradiotherapy for poor prognosis locally advanced bladder cancer.

  2001cited by this paper
• Bladder-sparing strategies for transitional cell carcinoma.

  2000cited by this paper
• Chemoradiotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program.

  2000cited by this paper
• Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.

  1999cited by this paper
• Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.

  1999cited by this paper
• Chemoradiotherapy of Locally Advanced Esophageal Cancer: Long-term Follow-up of a Prospective Randomized Trial (RTOG 85-01)

  1999cited by this paper
• The role of Ki67 proliferation assessment in predicting local control in bladder cancer patients treated by radical radiation therapy.

  1998cited by this paper
• The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience.

  1998cited by this paper
• Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of radiation therapy oncology group 89-03.

  1998cited by this paper
• Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: a long-term follow-up of 276 consecutive patients.

  1998cited by this paper
• A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.

  1998cited by this paper
• Combined treatment of invasive bladder carcinoma with transurethral resection, induction chemotherapy, and radical radiotherapy plus concomitant protracted infusion of cisplatin and 5‐fluorouracil

  1997cited by this paper
• Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.

  1997cited by this paper
• Combined chemotherapy and radiation with selective organ preservation for muscle-invasive bladder carcinoma. A single-institution phase II study.

  1997cited by this paper
• Bladder preservation by combined modality therapy for invasive bladder cancer.

  1997cited by this paper
• 42 A phase trial of transurethral surgery plus cisplatin and radiation therapy followed by either selective bladder preservation or radical cystectomy for patients with muscle-invading bladder cancer but without hydronephrosis

  1997cited by this paper
• Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

  1996cited by this paper
• Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.

  1996cited by this paper
• Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study.

  1996cited by this paper
• Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.

  1996cited by this paper
• Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.

  1996cited by this paper
• Production of DNA double-strand breaks by interactions between carboplatin and radiation: a potential mechanism for radiopotentiation.

  1995cited by this paper
• Bladder-sparing multimodality treatment of muscle-invasive bladder cancer: a five-year follow-up.

  1995cited by this paper
• 1161 Alternating chemo-radiotherapy in bladder cancer: A conservative approach

  1995cited by this paper
• Original Articles: Bladder Cancer

  1995cited by this paper
• Alternating chemo-radiotherapy in bladder cancer: a conservative approach.

  1995cited by this paper
• Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder. A multivariate survival analysis.

  1994cited by this paper
• Muscle-invasive bladder cancer treated with external beam radiotherapy: prognostic factors.

  1994cited by this paper
• Organ-sparing treatment of advanced bladder cancer: a 10-year experience.

  1994cited by this paper
• A pilot study of chemotherapy alternating with twice-a-day accelerated radiation therapy as an alternative to cystectomy in muscle infiltrating (stages T2 and T3) cancer of the bladder: preliminary results.

  1994cited by this paper
• Selective bladder preservation by combination treatment of invasive bladder cancer.

  1993cited by this paper
• Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study.

  1993cited by this paper
• Alternating chemo-radiotherapy for muscle-infiltrating bladder cancer

  1993cited by this paper
• Epidermoid Cancer of the Anus - the Surgeon Retreats

  1991cited by this paper
• Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification.

  1991cited by this paper
• Cisplatin and radiation: interaction probabilities and therapeutic possibilities.

  1990cited by this paper
• Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors.

  1990cited by this paper
• The effect of radiation and cytotoxic platinum compounds on the growth of normal and tumour bladder explant cultures.

  1990cited by this paper
• The effect of cis-diamminedichloroplatinum(II) on radiation damage in mouse rectum after fractionated irradiation.

  1989cited by this paper
• Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis.

  1989cited by this paper
• T2/T3 bladder carcinomas treated with definitive radiotherapy with emphasis on flow cytometric DNA ploidy values.

  1989cited by this paper
• Combined treatment of radiation and cisdiamminedichloroplatinum (II): a review of experimental and clinical data.

  1987cited by this paper
• Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer.

  1986cited by this paper
• The results of a series of 963 patients with transitional cell carcinoma of the urinary bladder primarily treated by radical megavoltage X-ray therapy.

  1986cited by this paper
• Primary radical radiotherapy for T3 transitional cell cancer of the bladder: an analysis of survival and control.

  1986cited by this paper
• Full-dose irradiation for patients with invasive bladder carcinoma: clinical and histological factors prognostic of improved survival.

  1985cited by this paper
• Experimental studies on the radiation‐modifying effect of cis‐diamminedichloroplatinum II (DDP) in human bladder transitional cell carcinomas grown in nude mice

  1983cited by this paper
• Concurrent radiation and cisplatin in the treatment of advanced bladder cancer: a preliminary report.

  1982cited by this paper
• Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy.

  1981cited by this paper

• Trimodal bladder-preserving treatment including high-tech radiotherapy in invasive bladder carcinoma-dissertation project with literature review

  2021cites this paper
• A systematic review and meta-analysis of radical cystectomy in the treatment of muscular invasive bladder cancer (MIBC)

  2021cites this paper
• Analytical study of bladder tumor

  2018cites this paper
• EVALUATION OF MULTIMODAL THERAPY USING ENDOSCOPIC RESECTION WITH CONCURRENT GEMCITABINE AND RADIOTHERAPY IN THE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER

  2014cites this paper
• The Impact of Chemoprevention on Treatment Regimens for Non- Muscle Invasive Bladder Cancer

  2011cites this paper
• Bladder preservation by concurrent chemoradiation for muscle-invasive bladder cancer: Applicability in low-income countries.

  2011cites this paper
• Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer

  2011cites this paper
• MUSCLE‐INVASIVE BLADDER TUMOUR: CAN THE BLADDER BE PRESERVED?

  2008cites this paper
• Bladder Cancer: Management and Future Directions

  2007cites this paper
• Phosphodiesterase‐5 inhibitors help climbers to achieve new heights

  2006cites this paper
• Quality of life after therapy for muscle-invasive bladder cancer

  2006cites this paper
• Evaluating the effect of reducing the high-dose volume on the toxicity of radiotherapy in the treatment of bladder cancer.

  2006cites this paper
• Techniques for the intradetrusor administration of botulinum toxin

  2006cites this paper
• The management of benign prostatic obstruction: a voice from the Third World

  2006cites this paper
• Anti‐emetic therapy: updating urological cancer‐care providers

  2006cites this paper
• Conservative treatment with transurethral resection, neoadjuvant chemotherapy followed by radiochemotherapy in stage T2-3 transitional bladder cancer

  2006cites this paper
• Novel therapies in bladder cancer.

  2005cites this paper